Clinical Trials Directory

Trials / Completed

CompletedNCT05550883

Aerobic Exercise for Women With Fibromyalgia

Effectiveness of Aerobic Exercises for Women With Fibromyalgia: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
October 6 University · Academic / Other
Sex
Female
Age
30 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This is randomized controlled trial that investigated the effect of aerobic exercises in women with fibromyalgia. The study was performed in Abu-kabir central hospital - Al Sharquia, Egypt. The sample was recruited from the rheumatology department in Abu-kabir central hospital- Al Sharquia. Sixty women were included in the study based on the inclusion criteria. The first group (study group) included 30 participants who received aerobic exercise in addition to the prescribed medications. The second group (control group) included 30 participants who received the prescribed medications only. The outcome measures included visual analogue scale, Fibromyalgia Impact Questionnaire and cholesterol level. Assessment of outcomes were performed at baseline and after the end of treatment program.

Conditions

Interventions

TypeNameDescription
OTHERAerobic exerciseThe patients in this group participated in aerobic exercise training for 45 minutes, three sessions per week for 6 weeks. They underwent the proper warm up to minimize the risk of musculoskeletal injury .The training session started by a proper warm up for 5 min in the form of mild stretching for the involved muscle group to prepare the exercised muscles and improve blood supply for skeletal muscle to prevent fatigue or injury. Patients in this study group performed aerobic exercise (in the form of treadmill training) All sessions were supervised to ensure correct technique and monitor the appropriate amount of exercise. The training session ended by a proper cooling down for 5 min to prevent fatigue or injury.
DRUGFibromyalgia Agentstricyclic antidepressants (low evening doses), and mostly when needed, low doses of: analgesics, muscle relaxants, hypnotics, and tranquilizers.

Timeline

Start date
2022-01-15
Primary completion
2022-09-01
Completion
2022-09-01
First posted
2022-09-22
Last updated
2022-09-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05550883. Inclusion in this directory is not an endorsement.